Promising results from a gene therapy study late last year by Hans Clevers, a Dutch stem cell researcher, showed that a technique called CRISPR can be used to correct the CFTR gene defect associated with cystic fibrosis in human stem cells. Using cultured intestinal stem cells, they were able to correct the defect. The researchers then grew the cells into intestinal “organoids,” or miniature guts, and showed that they functioned normally. In this case, about half of clonal organoids underwent the proper genetic correction, Clevers said.
This is a really interesting study that could see "true" gene therapy be applied via stem cells to the human body. There is still a lot of research to be done on this method, but the technology of correcting gene defects and sustainably incorporating them into cells and organs is actually here and has been demonstrated to work in mice and human stem cells.
source
Image taken from Cell publication
View attachment 448
This is a really interesting study that could see "true" gene therapy be applied via stem cells to the human body. There is still a lot of research to be done on this method, but the technology of correcting gene defects and sustainably incorporating them into cells and organs is actually here and has been demonstrated to work in mice and human stem cells.
source
Image taken from Cell publication
View attachment 448